Partnering

AstraZeneca has licensed a drug (IONIS-AZ6-2.5-LRx) from Ionis Pharmaceuticals, a Carlsbad, California-based pharmaceutical company, for treating nonalcoholic steatohepatitis (NASH), a liver disease, following advancement of the drug into development. IONIS-AZ6-2.5-LRx…

Boehringer Ingelheim (BI) and OSE Immunotherapeutics, a Nantes, France-headquartered biopharmaceutical company developing immunotherapies, have signed a worldwide collaboration and license agreement to jointly develop OSE-172, a signal regulatory protein (SIRP)-alpha…

Eli Lilly and Company and Sigilon Therapeutics, a Cambridge, Massachusetts-based cell-therapy company, have formed a global collaboration worth up to $473 million to develop encapsulated cell therapies for the potential…

Pfizer and Allogene Therapeutics, a San Francisco, California-headquartered biopharmaceutical company, have signed an asset contribution agreement for Pfizer’s portfolio of assets related to allogeneic chimeric antigen receptor T cell (CAR-T)…

Eisai and Nichi-Iko Pharmaceutical, a Japan-headquartered generic-drug company, have entered into a capital and business alliance as well as a share transfer agreement relating to their generic pharmaceuticals businesses, which…

Sosei Group, a Tokyo, Japan-headquartered biopharmaceutical company, has regained worldwide rights from Teva Pharmaceutical Industries to develop and commercialize Sosei’s lead calcitonin gene-related peptide (CGRP) drug candidate and other small…

Sanofi and Evotec AG, a Hamburg, Germany-based drug discovery and development company, have agreed to support Evotec in opening a new innovation platform near Lyon, France for infectious disease research…

Eisai and Merck & Co. have partnered for worldwide co-development and co-commercialization of Lenvima (lenvatinib mesylate), a drug for treating thyroid cancer discovered by Eisai, in a deal worth up…

Novartis has partnered with Pear Therapeutics, a Boston, Massachusetts-based prescription digital therapeutics company, to develop prescription digital therapeutics using software applications designed to treat disease and improve clinical outcomes for…

The National Institute for Bioprocessing Research and Training (NIBRT), a research and training institute for biomanufacturing in Ireland, has partnered with Jefferson (Philadelphia University + Thomas Jefferson University) to create…